The Government of India has banned 16 fixed-dose combination (FDC) medicines, prohibiting their manufacture, sale, distribution, and supply for human use with immediate effect across the country. The banned FDCs span therapeutic categories including antibiotics, pain management, antispasmodic drugs, and dermatological formulations. According to the Hindu, the banned fixed-dose combinations contain two or more active pharmaceutical ingredients in a fixed ratio. The Union Health Ministry deemed the 16 banned FDCs therapeutically unjustified and potentially risky, according to the Times of India. The decision was notified under Section 26A of the Drugs and Cosmetics Act, 1940, as reported by Free Press Journal. Among the prohibited FDCs are Acetyl Salicylic Acid with Ethoheptazine, combinations of Dicyclomine, Paracetamol and Clidinium Bromide, multi-drug formulations including Dicyclomine, Paracetamol, Clidinium Bromide and Chlordiazepoxide, and Gliclazide with Chromium Picolinate, according to Free Press Journal.